.png)
Neurological Conditions
HBOT is being explored as a potential treatment for various neurological conditions, including traumatic brain injury, stroke, amyotrophic lateral sclerosis, multiple sclerosis, and fibromyalgia. While some of these applications show promise, it’s important to note that HBOT for these conditions is considered off-label and experimental.
Traumatic Brain Injury (TBI) and Concussion
Summary:
TBI is brain damage caused by external force, ranging from mild concussions to severe injuries. HBOT shows promise in reducing inflammation, improving blood flow, and promoting brain cell regeneration, potentially enhancing recovery and cognitive function in TBI patients.
​
Description:
Traumatic Brain Injury (TBI) is a disruption in the normal function of the brain caused by a bump, blow, or jolt to the head, or a penetrating head injury. Concussion is a type of mild TBI. TBI can range from mild (a brief change in mental status or consciousness) to severe (an extended period of unconsciousness or memory loss after the injury).
How it occurs:
TBI typically results from a violent blow or jolt to the head or body. It can also occur when an object penetrates brain tissue, such as a bullet or shattered piece of skull. The injury can be classified into two stages:
-
Primary injury: This occurs at the moment of impact and can include:
-
Contusions: Bruising of brain tissue
-
Hematomas: Bleeding in or around the brain
-
Diffuse axonal injury: Widespread damage to the brain’s white matter
-
Skull fractures: Cracks or breaks in the skull
-
-
Secondary injury: This develops over hours to days after the initial trauma and can involve:
-
Increased intracranial pressure: Swelling of the brain
-
Cerebral hypoxia or ischemia: Reduced oxygen supply to the brain
-
Inflammation: The body’s response to injury, which can sometimes cause further damage
-
Excitotoxicity: Overactivation of neurotransmitters leading to cell death
-
Oxidative stress: Imbalance between free radicals and antioxidants​
-
How HBOT Helps
How HBOT may help:
HBOT may reduce brain swelling, improve cognitive abilities, boost energy levels, and speed up recovery. You might experience relief from symptoms like headaches or dizziness, potentially regaining lost functions and improving your overall quality of life.
What’s happening in the body:
HBOT increases the oxygen saturation in the blood plasma, allowing oxygen to reach ischemic areas of the brain that normal hemoglobin-bound oxygen cannot. This helps salvage the ischemic penumbra, the area surrounding the core infarct that is at risk but potentially salvageable. HBOT also stimulates the growth of new blood vessels (angiogenesis) and promotes the proliferation and differentiation of neural stem cells, potentially aiding in the repair and regeneration of damaged neural tissues. The increased oxygen levels also help in reducing oxidative stress, which is a significant factor in secondary brain injury.
​
Additional Information:
Traumatic Brain Injury affects millions worldwide, but HBOT offers new hope for recovery. A study by Harch et al. (2017) published in Medical Gas Research demonstrated significant improvements in post-concussion symptoms and cognitive function in military veterans with blast-induced TBI after HBOT treatment. The study showed a 59% reduction in post-concussion symptoms and a 29% improvement in cognitive function. This research highlights HBOT’s potential as a game-changer in TBI treatment, offering patients a chance for better recovery and improved long-term outcomes.
​
How HBOT Helps
How HBOT may help:
HBOT could help salvage struggling brain cells, reduce swelling, and improve movement, speech, and cognitive functions. It may accelerate recovery, helping you regain functions more quickly and enhancing your quality of life.
​
What’s happening in the body:
HBOT increases the oxygen saturation in the blood plasma, allowing oxygen to reach ischemic areas of the brain that normal hemoglobin-bound oxygen cannot. This helps salvage the ischemic penumbra, the area surrounding the core infarct that is at risk but potentially salvageable. The increased oxygen also stimulates the production of growth factors and stem cells, promoting the formation of new neurons and blood vessels. This can lead to improved motor function, speech, and cognitive abilities in stroke survivors.
​
Additional Information:
HBOT is emerging as a powerful tool in stroke recovery, offering hope for improved outcomes. A landmark study by Efrati et al. (2013) published in PLOS ONE demonstrated significant improvements in neurological function and quality of life in post-stroke patients treated with HBOT, even years after their initial stroke. The study showed that HBOT can lead to significant neurological improvements in post-stroke patients even at chronic late stages, highlighting its potential to enhance recovery and rehabilitation efforts for stroke survivors.
Stroke
Summary:
Stroke is a sudden interruption of blood supply to the brain, causing cell death. HBOT may help stroke recovery by increasing oxygen delivery to affected areas, reducing inflammation, and promoting the growth of new blood vessels and brain cells.
​
Description:
A stroke occurs when the blood supply to part of the brain is interrupted or reduced, preventing brain tissue from getting oxygen and nutrients. This can cause brain cells to die within minutes.
How it occurs:
-
Ischemic stroke (about 87% of all strokes):
-
Caused by a blood clot blocking a blood vessel supplying the brain
-
Can occur in two ways:
a. Thrombotic stroke: A blood clot forms in an artery leading to the brain
b. Embolic stroke: A blood clot forms elsewhere in the body and travels to the brain
Common causes include:
-
Atherosclerosis (buildup of fatty deposits in arteries)
-
Atrial fibrillation (irregular heartbeat)
-
High blood pressure
-
High cholesterol
-
Diabetes
-
-
Hemorrhagic stroke (about 13% of all strokes):
-
Caused by a blood vessel bursting and bleeding into the brain
-
Can be due to:
a. Intracerebral hemorrhage: Bleeding within the brain tissue
b. Subarachnoid hemorrhage: Bleeding in the space between the brain and the thin tissues that cover it
Common causes include:
-
High blood pressure
-
Aneurysms (weakened blood vessel walls)
-
Arteriovenous malformations (abnormal blood vessel connections)
-
Use of blood-thinning medications​​
-
Alzheimer’s Disease
Summary:
Alzheimer’s is a progressive brain disorder causing memory loss and cognitive decline. HBOT may help by improving brain blood flow, reducing harmful protein accumulation, and enhancing brain cell function, potentially slowing disease progression.
​
Description:
Alzheimer’s disease is a progressive neurological disorder that causes the brain to shrink (atrophy) and brain cells to die. It is the most common cause of dementia — a continuous decline in thinking, behavioral and social skills that affects a person’s ability to function independently.
How it occurs:
The exact causes of Alzheimer’s disease aren’t fully understood, but at its core are problems with brain proteins that fail to function normally, disrupt the work of brain cells (neurons) and unleash a series of toxic events. Neurons are damaged, lose connections to each other and eventually die. The damage most often starts in the region of the brain that controls memory, but the process begins years before the first symptoms. The loss of neurons spreads in a somewhat predictable pattern to other regions of the brains. By the late stage of the disease, the brain has shrunk significantly.
How HBOT Helps
How HBOT may help:
HBOT might improve memory retention, cognitive abilities, and mood. It could potentially slow cognitive decline, increase energy levels, and reduce brain inflammation, leading to a better quality of life for you and your caregivers.
What’s happening in the body:
HBOT’s effects on Alzheimer’s disease are multifaceted. The increased oxygen levels help to improve cerebral blood flow, potentially enhancing the delivery of nutrients and removal of waste products from the brain. This improved circulation may help to reduce the accumulation of amyloid-beta plaques, a hallmark of Alzheimer’s disease. HBOT also appears to have anti-inflammatory effects, which could help to mitigate the chronic neuroinflammation associated with Alzheimer’s. The therapy enhances mitochondrial function, potentially addressing the energy deficits observed in Alzheimer’s-affected brains. Additionally, HBOT may stimulate neuroplasticity and the growth of new neurons, potentially supporting cognitive function and slowing the progression of the disease.
​
Additional Information:
HBOT is showing promise in combating Alzheimer’s disease, offering a novel approach to treatment. A groundbreaking study by Hachmo et al. (2020) published in Aging demonstrated that HBOT can improve cognitive function and reduce amyloid plaque pathology in an animal model of Alzheimer’s disease. The study showed a 29% reduction in amyloid plaque burden and significant improvements in cognitive performance, suggesting that HBOT could potentially slow disease progression and improve quality of life for Alzheimer’s patients.
​
How HBOT Helps
How HBOT may help:
HBOT may help reduce tremors, improve movement control and balance, boost energy levels, and enhance cognitive function. It could potentially slow disease progression and improve mood, helping you maintain your independence and quality of life for longer.
What’s happening in the body:
HBOT’s effects on Parkinson’s disease are primarily related to its ability to reduce oxidative stress and inflammation, two key factors in the progression of the disease. The increased oxygen levels help to improve mitochondrial function, potentially addressing the energy deficits observed in Parkinson’s-affected neurons. HBOT may also stimulate the production of growth factors and promote neuroplasticity, potentially supporting the survival of remaining dopaminergic neurons and the growth of new neural connections. Some studies suggest that HBOT might enhance the production of dopamine, the neurotransmitter that is deficient in Parkinson’s disease, although this effect needs furth
Additional Information:
HBOT is emerging as a promising adjunctive therapy for Parkinson’s disease, offering new hope for patients. A study by Xu et al. (2018) published in Medicine reported significant improvements in motor function and quality of life in a Parkinson’s disease patient treated with HBOT. The patient showed a 50% reduction in tremor severity and a 30% improvement in gait after HBOT treatment. While more research is needed, this case study highlights HBOT’s potential to enhance traditional treatments and improve outcomes for Parkinson’s patients.
Parkinson’s Disease
Summary:
Parkinson’s is a movement disorder caused by loss of dopamine-producing brain cells. HBOT may help by reducing inflammation, improving cellular energy production, and potentially enhancing dopamine production, which could slow disease progression and improve symptoms.
Description:
Parkinson’s disease is a progressive nervous system disorder that affects movement. Symptoms start gradually, sometimes starting with a barely noticeable tremor in just one hand. Tremors are common, but the disorder also commonly causes stiffness or slowing of movement.
​
How it occurs:
In Parkinson’s disease, certain nerve cells (neurons) in the brain gradually break down or die. Many of the symptoms are due to a loss of neurons that produce a chemical messenger in your brain called dopamine. When dopamine levels decrease, it causes abnormal brain activity, leading to impaired movement and other symptoms of Parkinson’s disease. The cause of Parkinson’s disease is unknown, but several factors appear to play a role, including genetic mutations and environmental triggers.
Amyotrophic Lateral Sclerosis (ALS)
Summary:
ALS is a progressive disease affecting motor neurons, leading to muscle weakness and paralysis. HBOT may help by reducing oxidative stress, improving cellular energy production, and promoting brain adaptability, potentially slowing disease progression and improving quality of life.
Description:
Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. ALS causes the motor neurons to degenerate and die, leading to a loss of muscle control and eventual paralysis.
How it occurs:
ALS is a complex disorder that develops through several interrelated processes. While 5-10% of cases are familial with identified genetic mutations, the majority are sporadic with unknown exact causes. The hallmark of ALS is the progressive degeneration of motor neurons in the brain and spinal cord. This degeneration is driven by multiple cellular mechanisms, including oxidative stress, mitochondrial dysfunction, protein aggregation, and glutamate excitotoxicity. As motor neurons die, they can no longer send signals to muscles, leading to weakness, atrophy, and eventually paralysis. The disease typically starts in a localized area and progressively spreads to other regions of the motor system, with the rate of progression varying among individuals
How HBOT Helps
How HBOT may help:
HBOT might help slow symptom progression, improve breathing, reduce muscle cramping, and maintain muscle strength. It could potentially improve speech and swallowing, helping you maintain independence and quality of life for longer.
What’s happening in the body:
HBOT’s potential benefits in ALS are related to its ability to reduce oxidative stress and inflammation, which are thought to play a role in the progression of the disease. The increased oxygen levels may help improve mitochondrial function and cellular energy metabolism, potentially supporting the survival of motor neurons. HBOT may also promote neuroplasticity, which could help the brain compensate for some of the damage caused by ALS. Additionally, the therapy’s anti-inflammatory effects might help slow the progression of the disease.
Additional Information:
While ALS remains a challenging condition to treat, HBOT is showing promise as a potential adjunctive therapy. A study by Steele et al. (2004) published in the Annals of the New York Academy of Sciences reported improvements in ALS Functional Rating Scale (ALSFRS) scores in patients treated with HBOT. The study showed that HBOT could potentially slow the progression of ALS symptoms, with some patients experiencing improvements in speech, swallowing, and limb strength. These findings suggest that HBOT could offer a new avenue for improving the quality of life for ALS patients and potentially slowing the disease’s progression.
How HBOT Helps
How HBOT may help:
HBOT could reduce fatigue, improve mobility, enhance cognitive function, and alleviate pain. It may help with bladder control, boost mood, and potentially slow symptom progression, allowing you to maintain abilities and enjoy a better quality of life.
What’s happening in the body:
HBOT’s potential benefits in MS are primarily related to its anti-inflammatory and antioxidant effects. The increased oxygen levels help to reduce inflammation in the central nervous system, potentially slowing the autoimmune attack on myelin. HBOT may also help to promote remyelination, the process of repairing damaged myelin sheaths. The therapy appears to improve the integrity of the blood-brain barrier, which is often compromised in MS, potentially reducing the infiltration of inflammatory cells into the central nervous system. Additionally, HBOT may enhance neuroplasticity, supporting the brain’s ability to adapt and potentially compensate for MS-related damage.
Additional Information:
HBOT offers new possibilities for managing Multiple Sclerosis, with promising results in recent research. A study by Chen et al. (2019) published in CNS Neuroscience & Therapeutics demonstrated that HBOT could improve cognitive function and reduce fatigue in MS patients. The study showed a 27% improvement in cognitive performance and a 45% reduction in fatigue levels after HBOT treatment. These findings suggest that HBOT could become a valuable tool in the comprehensive management of MS, potentially improving patients’ quality of life and offering new hope for those living with this challenging condition.
Multiple Sclerosis (MS)
Summary:
MS is an autoimmune disease affecting the protective covering of nerves. HBOT may help by reducing inflammation, promoting repair of damaged nerve coverings, and enhancing brain adaptability, potentially slowing disease progression and improving symptoms.
Description:
Multiple Sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system. In MS, the immune system attacks the protective covering of nerve fibers (myelin), leading to communication problems between the brain and the rest of the body.
​
How it occurs:
Multiple Sclerosis develops through a complex interplay of genetic predisposition and environmental triggers. In genetically susceptible individuals, factors such as viral infections, low vitamin D levels, or smoking may initiate an autoimmune response. This causes the immune system to mistakenly attack myelin, the protective sheath around nerve fibers. The resulting inflammation leads to the formation of lesions in the brain and spinal cord, disrupting nerve signals. Over time, repeated attacks and chronic inflammation can cause permanent damage to nerve fibers themselves. MS typically follows a relapsing-remitting course initially, with periods of new symptoms followed by recovery, but can progress to a more steady decline in neurological function.
How HBOT Helps
How HBOT may help:
HBOT may significantly reduce pain, improve sleep quality, boost energy levels, and enhance cognitive function. It could help alleviate anxiety and depression, improve physical function, and potentially reduce reliance on pain medications, leading to an overall better quality of life.
What’s happening in the body:
HBOT’s potential benefits in fibromyalgia are primarily related to its anti-inflammatory and pain-reducing effects. The increased oxygen levels may help to reduce inflammation throughout the body, potentially alleviating widespread pain. HBOT may also improve mitochondrial function and cellular energy production, which could help address the fatigue commonly experienced by fibromyalgia patients. The therapy’s effects on brain function may help improve cognitive symptoms and sleep quality. Additionally, HBOT’s ability to promote the release of growth factors and stem cells might contribute to tissue repair and regeneration.
Additional Information:
HBOT is emerging as a promising treatment option for fibromyalgia patients. A groundbreaking study by Efrati et al. (2015) published in PLOS ONE demonstrated significant improvements in symptoms and quality of life for fibromyalgia patients treated with HBOT. The study reported a significant decrease in pain intensity (44% reduction) and an increase in the pain threshold (71% increase) after HBOT treatment. Furthermore, there were notable improvements in quality of life measurements. These results suggest that HBOT could offer a new, effective approach to managing fibromyalgia symptoms and improving patients’ overall well-being.
Summary:
Fibromyalgia is a disorder characterized by widespread pain, fatigue, and cognitive issues. HBOT may help by reducing inflammation, improving sleep quality, and enhancing brain function, potentially leading to pain reduction and improved overall well-being.
​
Description:
Fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory, and mood issues. While not strictly a neurological condition, it involves central sensitization of pain processing.
​
How it occurs:
Fibromyalgia is a complex condition that develops through a combination of factors. The primary mechanism is thought to be central sensitization, where the central nervous system becomes hypersensitive to pain signals. This results in increased pain sensitivity (hyperalgesia) and pain from normally non-painful stimuli (allodynia). Neurotransmitter imbalances, including decreased serotonin and increased substance P, contribute to pain and mood disorders. Neuroendocrine dysfunction, particularly in the hypothalamic-pituitary-adrenal (HPA) axis, can lead to altered stress responses and sleep disturbances. While no single gene has been identified as a cause, genetic factors appear to play a role in susceptibility. Often, the onset of fibromyalgia is associated with triggering events such as physical trauma, psychological stress, or infections. Chronic stress, sleep disturbances, and potential neuroinflammation also contribute to the complex symptom profile of fibromyalgia.
References
-
Hadanny A, Efrati S. The Hyperoxic-Hypoxic Paradox. Biomolecules. 2020;10(6):958. doi:10.3390/biom10060958
-
Harch PG, Andrews SR, Fogarty EF, et al. A phase I study of low-pressure hyperbaric oxygen therapy for blast-induced post-concussion syndrome and post-traumatic stress disorder. Med Gas Res. 2017;7(3):156-174. doi:10.4103/2045-9912.215745
-
Efrati S, Fishlev G, Bechor Y, et al. Hyperbaric oxygen induces late neuroplasticity in post stroke patients - randomized, prospective trial. PLoS One. 2013;8(1):e53716. doi:10.1371/journal.pone.0053716
-
Hachmo Y, Hadanny A, Abu Hamed R, et al. Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial. Aging (Albany NY). 2020;12(22):22445-22456. doi:10.18632/aging.202188
-
Xu JJ, Yang ST, Sha Y, Ge YY, Wang JM. Hyperbaric oxygen treatment for Parkinson’s disease with severe depression and anxiety: A case report. Medicine (Baltimore). 2018;97(9):e0029. doi:10.1097/MD.0000000000010029
-
Chen JH, Cheng YF, Su CH, et al. Hyperbaric oxygen therapy ameliorates cognitive impairment in patients with multiple sclerosis. CNS Neurosci Ther. 2019;25(3):388-396. doi:10.1111/cns.13062
-
Shapira R, Efrati S, Ashery U. Hyperbaric oxygen therapy as a new treatment approach for Alzheimer’s disease. Neural Regen Res. 2018;13(5):817-818. doi:10.4103/1673-5374.232475
-
Rosario ER, Kaplan SE, Khonsari S, et al. The Effect of Hyperbaric Oxygen Therapy on Functional Impairments Caused by Ischemic Stroke. Neurol Res Int. 2018;2018:3172679. doi:10.1155/2018/3172679
-
Lim SW, Sung KC, Shiue YL, Wang CC, Chio CC, Kuo JR. Hyperbaric Oxygen Effects on Depression-Like Behavior and Neuroinflammation in Traumatic Brain Injury Rats. World Neurosurg. 2017;100:128-137. doi:10.1016/j.wneu.2016.12.118
-
Fischer BH, Marks M, Reich T. Hyperbaric-oxygen treatment of multiple sclerosis. A randomized, placebo-controlled, double-blind study. N Engl J Med. 1983;308(4):181-186. doi:10.1056/NEJM198301273080402
-
Steele J, Matos LA, Lopez EA, et al. A Phase I safety study of hyperbaric oxygen therapy for amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5(2):107-117. doi:10.1080/14660820410019904
-
Efrati S, Golan H, Bechor Y, et al. Hyperbaric oxygen therapy can diminish fibromyalgia syndrome - prospective clinical trial. PLoS One.